Ameritas Investment Partners’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-10,046
| Closed | -$527K | – | 3146 |
|
|
2020
Q3 | $527K | Sell |
10,046
-369
| -4% | -$15.3K | 0.02% | 708 |
|
|
2020
Q2 | $347K | Buy |
10,415
+587
| +6% | +$18.7K | 0.02% | 805 |
|
|
2020
Q1 | $267K | Buy |
9,828
+1,224
| +14% | +$34.1K | 0.02% | 821 |
|
|
2019
Q4 | $170K | Buy |
8,604
+572
| +7% | +$9.15K | 0.01% | 1193 |
|
|
2019
Q3 | $104K | Hold |
8,032
| – | – | ﹤0.01% | 1448 |
|
|
2019
Q2 | $100K | Hold |
8,032
| – | – | ﹤0.01% | 1507 |
|
|
2019
Q1 | $117K | Buy |
8,032
+1,586
| +25% | +$20.3K | 0.01% | 1377 |
|
|
2018
Q4 | $71K | Hold |
6,446
| – | – | ﹤0.01% | 1608 |
|
|
2018
Q3 | $170K | Hold |
6,446
| – | – | 0.01% | 1198 |
|
|
2018
Q2 | $132K | Hold |
6,446
| – | – | 0.01% | 1349 |
|
|
2018
Q1 | $117K | Hold |
6,446
| – | – | 0.01% | 1402 |
|
|
2017
Q4 | $90K | Hold |
6,446
| – | – | ﹤0.01% | 1556 |
|
|
2017
Q3 | $108K | Hold |
6,446
| – | – | 0.01% | 1413 |
|
|
2017
Q2 | $109K | Buy |
6,446
+834
| +15% | +$12.7K | 0.01% | 1418 |
|
|
2017
Q1 | $75K | Buy |
+5,612
| New | +$87.9K | ﹤0.01% | 1598 |
|
Ameritas Investment Partners's MNTA Position: Q4 2020 in Review
Ameritas Investment Partners sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 10,046 shares — an estimated $527K sold.
Ameritas Investment Partners first reported a position in MNTA in Q1 2017 and held it in 15 quarters. The position peaked at $527K in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.
- Ameritas Investment Partners reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
- Ameritas Investment Partners sold 10,046 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $527K.
- Ameritas Investment Partners first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2017 and held it in 15 quarters.
- Ameritas Investment Partners's Momenta Pharmaceuticals, Inc. position peaked at $527K in Q3 2020.
- 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.
Based on Ameritas Investment Partners's 13F filing for Q4 2020, filed 12 Feb 2021.